Skip to main content
logo
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
58.55
+0.76 (1.32%)
At close: Aug 27, 2026

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
26,88226,56417,23719,53016,03014,959
Market Cap Growth
-29.37%54.11%-11.74%21.83%7.16%-
Enterprise Value
26,50025,70417,34218,89114,51814,805
Last Close Price
57.7957.6041.4747.8539.3737.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
27.7533.1647.89213.94-1454.37
PB Ratio
23.8120.5086.1623.019.126.07
P/TBV Ratio
35.8429.60-50.5112.667.53

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
27.3532.0848.18206.94-1439.37

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.200.965.790.480.050.04
Net Debt / Equity Ratio
-0.34-0.541.59-0.40-0.76-0.81
Net Debt / EBITDA Ratio
0.630.90-0.340.301.773.12
Net Debt / FCF Ratio
0.540.92-0.400.341.973.97
Asset Turnover
0.320.340.220.05-0.01
Inventory Turnover
0.950.840.280.54--
Quick Ratio
2.492.111.111.785.709.82
Current Ratio
2.632.221.272.035.939.96
Return on Equity (ROE)
-43.70%-102.76%-179.21%-84.98%-34.87%-37.83%
Return on Assets (ROA)
-13.54%-21.71%-37.81%-40.35%-20.52%-21.46%
Return on Capital Employed (ROCE)
-31.80%-40.60%-104.20%-110.20%-43.20%-26.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.22%-2.88%-4.91%-5.67%-4.59%-4.48%
FCF Yield
-2.61%-2.86%-4.57%-5.12%-4.22%-3.35%
Buyback Yield / Dilution
-9.39%-7.75%-1.83%-0.70%-12.29%-0.07%